网站主页 >> CAS数据库列表 >> (2R,3S,4R,5R)-2-(羟基甲基)-5-(6-甲基-9H-嘌呤-9-基)四氢呋喃-3,4-二醇
(2R,3S,4R,5R)-2-(羟基甲基)-5-(6-甲基-9H-嘌呤-9-基)四氢呋喃-3,4-二醇
|
|
- CAS号:
- 14675-48-0
- 英文名:
- 6-methylpurine riboside
- 英文别名:
- 6-D-MPR;Nsc101619;6-METHYLPURINE;6-METHYLPURINE RIBOSIDE;6-Methylpurine-β-D-riboside;6-Methylpurine ribonucleoside;6-Methylpurine-beta-D-riboside;6-Methyl-9-(1-β-D-ribofuranosyl)purine;6-Methyl-9.beta.-D-ribofuranosylpurine;6-Methylpurine-9-beta-D-ribofuranoside
- 中文名:
- (2R,3S,4R,5R)-2-(羟基甲基)-5-(6-甲基-9H-嘌呤-9-基)四氢呋喃-3,4-二醇
- 中文别名:
- 6-甲基嘌呤核糖;6-甲基嘌呤核糖苷;6-甲基嘌呤-BETA-D-核糖苷;6-甲基-9-BETA-D-呋喃核糖基嘌呤;化合物 6-METHYLPURINE-BETA-D-RIBOSIDE, 6-D-MPR;(2R,3S,4R,5R)-2-(羟基甲基)-5-(6-甲基-9H-嘌呤-9-基)四氢呋喃-3,4-二醇
- CBNumber:
- CB1404142
- 分子式:
- C11H14N4O4
- 分子量:
- 266.25
- MOL File:
- 14675-48-0.mol
|
|
|
(2R,3S,4R,5R)-2-(羟基甲基)-5-(6-甲基-9H-嘌呤-9-基)四氢呋喃-3,4-二醇化学性质
-
熔点:
-
209-210 °C
-
|
-
沸点:
-
590.4±60.0 °C(Predicted)
-
|
-
密度:
-
1.81±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
Sealed in dry,Store in freezer, under -20°C
-
|
-
形态:
-
Solid
-
|
-
酸度系数(pKa):
-
13.13±0.70(Predicted)
-
|
-
颜色:
-
White to off-white
-
|
-
InChI:
-
InChI=1/C11H14N4O4/c1-5-7-10(13-3-12-5)15(4-14-7)11-9(18)8(17)6(2-16)19-11/h3-4,6,8-9,11,16-18H,2H2,1H3/t6-,8-,9-,11-/s3
-
|
-
InChIKey:
-
FIGBCBGMUIGJBD-SOMIAQKHNA-N
-
|
-
SMILES:
-
N1(C=NC2C(C)=NC=NC1=2)[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 |&1:10,11,13,15,r|
-
|
(2R,3S,4R,5R)-2-(羟基甲基)-5-(6-甲基-9H-嘌呤-9-基)四氢呋喃-3,4-二醇性质、用途与生产工艺
(2R,3S,4R,5R)-2-(羟基甲基)-5-(6-甲基-9H-嘌呤-9-基)四氢呋喃-3,4-二醇 是一种嘌呤核苷类似物。嘌呤核苷类似物具有广泛的抗肿瘤活性,靶向惰性淋巴系统恶性肿瘤。这一过程中的抗癌机制依赖于抑制 DNA 合成,诱导细胞凋亡 (apoptosis) 等。
(2R,3S,4R,5R)-2-(羟基甲基)-5-(6-甲基-9H-嘌呤-9-基)四氢呋喃-3,4-二醇
上下游产品信息
上游原料
下游产品
(2R,3S,4R,5R)-2-(羟基甲基)-5-(6-甲基-9H-嘌呤-9-基)四氢呋喃-3,4-二醇
生产厂家
14675-48-0, (2R,3S,4R,5R)-2-(羟基甲基)-5-(6-甲基-9H-嘌呤-9-基)四氢呋喃-3,4-二醇 相关搜索:
- 抑制剂
- 核苷
- 化合物 6-METHYLPURINE-BETA-D-RIBOSIDE, 6-D-MPR
- 6-甲基嘌呤核糖苷
- 6-甲基嘌呤核糖
- 6-甲基嘌呤-BETA-D-核糖苷
- (2R,3S,4R,5R)-2-(羟基甲基)-5-(6-甲基-9H-嘌呤-9-基)四氢呋喃-3,4-二醇
- 6-甲基-9-BETA-D-呋喃核糖基嘌呤
- 14675-48-0
- (2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-methyl-9H-purin-9-yl)oxolane-3,4-diol
- 6-methyl-9-β-D-ribofuranosyl-9H-purine
- 6-METHYLPURINE
- 6-Methyl-9-(beta-D-ribofuranosyl)-9H-purine, natural antibiotics, antifungal antiviral agent
- (2r,3s,4r,5r)-2-(hydroxymethyl)-5-(6-methyl-1H-purin-9-yl)tetrahydrofuran-3,4-diol
- 6-Methylpurine-β-D-riboside
- 9H-Purine, 6-methyl-9-β-D-ribofuranosyl-
- 9H-Purine, 6-methyl-9-b-D-ribofuranosyl-
- 6-Methyl-9-(beta-D-ribofuranosyl)-9H-purine
- 6-Methyl-9-(1-β-D-ribofuranosyl)purine
- (2R,3S,4R,5R)-2-(HydroxyMethyl)-5-(6-Methyl-9H-purin-9-yl)tetrahydrofuran-3,4-diol
- 6-Methylpurine-9-beta-D-ribofuranoside
- 6-Methylpurine-beta-D-riboside
- 6-D-MPR
- Nsc101619
- 9H-Purine, 6-methyl-9-.beta.-D-ribofuranosyl-
- 6-Methylpurine ribonucleoside
- 6-Methyl-9.beta.-D-ribofuranosylpurine
- 6-METHYLPURINE RIBOSIDE